Covista Inc. (CVSA)
NYSE: CVSA · Real-Time Price · USD
131.82
+0.20 (0.15%)
Oct 23, 2026, 4:00 PM EDT - Market closed
Covista Financials Overview
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Revenue Revenue Growth | 1,954 | 1,954 | 1,788 | 1,585 | 1,451 | 1,382 |
Revenue Growth | 9.27% | 9.27% | 12.85% | 9.22% | 4.99% | 53.67% |
Gross Profit Gross Profit Growth | 1,120 | 1,120 | 1,017 | 886.1 | 802.34 | 722.07 |
Operating Income Operating Income Growth | 389.71 | 389.71 | 345.75 | 271.64 | 226.33 | 155.57 |
Net Income Net Income Growth | 251.57 | 251.57 | 237.07 | 136.78 | 93.36 | 310.99 |
Earnings Per Share EPS Growth | 7.05 | 7.05 | 6.18 | 3.40 | 2.05 | 6.43 |
EPS Growth | 13.95% | 13.95% | 82.07% | 66.03% | -68.17% | 373.48% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Chamberlain Chamberlain Growth | 750.21 | 750.21 | 725.77 | 633.52 | 571.03 | 557.54 |
Walden Walden Growth | 804.93 | 804.93 | 693.43 | 595.33 | 533.73 | 485.39 |
Medical and Veterinary Medical and Veterinary Growth | 398.94 | 398.94 | 369.09 | 355.8 | 346.07 | 338.91 |
Revenue (Total) Revenue (Total) Growth | 1,954 | 1,954 | 1,788 | 1,585 | 1,451 | 1,382 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Investments Cash & Investments Growth | 406.32 | 406.32 | 199.6 | 219.31 | 272.19 | 346.97 |
Total Debt Total Debt Growth | 905.5 | 905.5 | 774 | 847.85 | 896.19 | 1,067 |
Net Cash (Debt) Net Cash Growth | -499.18 | -499.18 | -574.4 | -628.55 | -624 | -719.76 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -13.98 | -13.98 | -14.98 | -15.59 | -13.68 | -14.87 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 470.42 | 470.42 | 337.9 | 295.78 | 191.91 | 10.6 |
Capital Expenditures CapEx Growth | -77.7 | -77.7 | -50.33 | -48.89 | -26.01 | -31.05 |
Free Cash Flow Free Cash Flow Growth | 392.73 | 392.73 | 287.57 | 246.88 | 165.9 | -20.45 |
Free Cash Flow Growth | 36.57% | 36.57% | 16.48% | 48.81% | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Gross Margin | 57.34% | 57.34% | 56.86% | 55.92% | 55.30% | 52.25% |
Operating Margin | 19.94% | 19.94% | 19.33% | 17.14% | 15.60% | 11.26% |
Pretax Margin | 17.66% | 17.66% | 16.69% | 10.35% | 7.72% | -3.73% |
Profit Margin | 12.87% | 12.87% | 13.26% | 8.63% | 6.44% | 22.51% |
FCF Margin | 20.10% | 20.10% | 16.08% | 15.58% | 11.43% | -1.48% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 25, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 18.70 | 16.86 | 19.28 | 18.75 | 16.04 | 5.22 |
Forward PE | 14.57 | 14.68 | 17.52 | 12.45 | 8.09 | 8.61 |
P/FCF Ratio | 11.43 | 10.80 | 15.90 | 10.39 | 9.03 | - |
PS Ratio | 2.30 | 2.17 | 2.56 | 1.62 | 1.03 | 1.18 |